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The embryonic stem (ES) cell transcriptional and
chromatin-modifying networks are critical for self-
renewal maintenance. However, it remains unclear
whether these networks functionally interact and, if
so, what factors mediate such interactions. Here,
we show that WD repeat domain 5 (Wdr5), a core
member of the mammalian Trithorax (trxG) complex,
positively correlates with the undifferentiated state
and is a regulator of ES cell self-renewal. We demon-
strate that Wdr5, an ‘‘effector’’ of H3K4 methylation,
interacts with the pluripotency transcription factor
Oct4. Genome-wide protein localization and tran-
scriptome analyses demonstrate overlapping gene
regulatory functions between Oct4 and Wdr5. The
Oct4-Sox2-Nanog circuitry and trxG cooperate in
activating transcription of key self-renewal regula-
tors, and furthermore, Wdr5 expression is required
for the efficient formation of induced pluripotent
stem (iPS) cells. We propose an integrated model
of transcriptional and epigenetic control, mediated
by select trxG members, for the maintenance of ES
cell self-renewal and somatic cell reprogramming.
INTRODUCTION
The maintenance of ES cell self-renewal requires a network of
transcription factors, including Oct4, Sox2, Nanog, Esrrb, Tbx3,
and Tcf3 (Chen et al., 2008; Ivanova et al., 2006; Kim et al.,
2008; Tam et al., 2008). These factors participate in auto- and
cross-regulatory interactions to increase their own expression
and that of other self-renewal-associated geneswhile repressinggenes that promote differentiation. Perturbation of these factors
collapses the self-renewal circuitry and triggers specific ormixed
lineage differentiation (Ivanova et al., 2006). In contrast to the
numerous transcription factors, only a handful of chromatin regu-
lators that are important for self-renewal havebeencharacterized
(Loh et al., 2007; Pasini et al., 2007; Schaniel et al., 2009).
ES cells harbor an open, transcriptionally permissive chromatin
that allows for efficient epigenomic remodeling during lineage
commitment (Efroni et al., 2008). However, factors regulating this
‘‘hyperdynamic’’ epigenetic configuration remain poorly under-
stood. ES cells also contain ‘‘bivalent domains’’ where nucleo-
somes are marked by trimethylation at histone3-lysine27
(H3K27me3) and histone3-lysine4 (H3K4me3) (Bernstein et al.,
2006). The Polycomb group (PcG) complex mediates
H3K27me3, correlated with gene repression (Boyer et al., 2006).
In contrast, the Trithorax group (trxG) complex mediates
H3K4me3, generally correlated with gene activation (Ringrose
and Paro, 2004). Although PcG has been extensively investigated
in the maintenance of ES cell self-renewal, pluripotency, and
somatic cell reprogramming, there exists little complementary
information for trxG-associated members. This imbalance of
knowledge represents a significant shortcoming in the under-
standing of the roles played by trimethylated H3K4 and H3K27 in
regulating the ES cell identity. Moreover, it remains to be shown
whether thewell-established transcriptional network can function-
ally interact with epigenetic regulators to maintain pluripotency
and, more importantly, which factors mediate such interactions.
An unresolved question in chromatin biology is the manner by
which generic histone modification complexes, like PcG and
trxG, become targeted to specific genomic loci to direct specific
gene regulatory functions (Schuettengruber et al., 2007). This is
especially intriguing in the context of ES cells. For example,
Chd1, a chromodomain-helicase-DNA-binding protein that is
not specific to ES cells, was recently described to be essential
for pluripotency and reprogramming (Gaspar-Maia et al.,Cell 145, 183–197, April 15, 2011 ª2011 Elsevier Inc. 183
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Figure 1. Downregulation of Wdr5 Expression upon ES Cell Differentiation
(A) Heatmap of trxG-associated member expressions during RA induction from Ivanova et al. (2006).
(B and C) Real-time PCR (left) and immunoblot (right) analyses during RA induction and EB formation.
(D) Real-time PCR analysis after 3 days shRNA knockdown of Nanog and Oct4.
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2009). The factor(s) or mechanism(s) conferring such functional
specificity to epigenetic regulators remains unknown. Moreover,
it is unclear how ectopic expression of four transcription
factors—Oct4, Sox2, Klf4, and c-Myc (OSKM)—can reprogram
somatic cells to iPS cells with epigenomes that are largely indis-
tinguishable from ES cells (Carvajal-Vergara et al., 2010; Tsai
et al., 2010). This is especially pertinent to the re-establishment
of the bivalent signature. Interestingly, although the OSKM-iPS
methodology has been replaced by various combinations of
factors or small molecules, Oct4 remains the sole factor that,
until recently, could not be substituted/omitted (Heng et al.,
2010). Accordingly, we reasoned that the resetting of the
somatic epigenome must be achieved through the activity of
Oct4-interacting proteins and/or Oct4 target genes.
Protein complexes of the Set/MLL histone methyltransferase
(HMT) family are mammalian homologs of trxG that function as
conserved, multisubunit ensembles to catalyze the methylation
of H3K4. The human MLL gene, which contains a SET domain,
was first identified based on translocations that are commonly
associated with the pathogenesis of multiple forms of hemato-
logical malignancies (Shilatifard, 2006). Notably, Set/MLL
proteins alone are catalytically inactive but require core
subunits—Wdr5, Ash2l and Rbbp5—that are related to compo-
nents of the yeast Set1 complex (Dou et al., 2006). The Rbbp5
and Ash2l heterodimer directly participates in HMT activity of
the MLL1 complex (Cao et al., 2010). Ash2l is required for mouse
embryogenesis (Taylor et al., 2010) and proper X-inactivation
(Pullirsch et al., 2010), whereas diminished recruitment of
Rbbp5 is found in patients with Wiskott-Aldrich syndrome (Stol-
ler et al., 2010). Other trxG-associated cofactors such as Menin,
Hcf1, and Cxxc1 have been implicated in processes like pancre-
atic b cell growth (Karnik et al., 2007), tumorigenesis (Lairmore
and Chen, 2009), apoptosis (Tyagi and Herr, 2009), and euchro-
matin formation (Thomson et al., 2010). In particular, Wdr5 is
a key component of trxG acting as a ‘‘presenter’’ of the H3K4
residue and is indispensible for Set/MLL complex assembly
and effective HMT activity (Dou et al., 2006). It was shown that
Wdr5 interacts with H3K4me2 and mediates transition to the tri-
methylated state (Wysocka et al., 2005). However, it was also
shown that Wdr5 is unable to distinguish between different
H3K4 methylation states (Couture et al., 2006). Although Wdr5
function is required for vertebrate development (Wysocka
et al., 2005) and osteoblast differentiation (Zhu et al., 2008), its
role in ES or iPS cells remains to be determined.
RESULTS
Wdr5 Expression Positively Correlates with
the Undifferentiated ES Cell State
We sought to functionally characterize specific chromatin
regulators in the maintenance of ES cell self-renewal, with
a particular focus on trxG-associated members. For this, we(E) Real-time PCR analysis in Nanog-inducible (Ivanova et al., 2006), Oct4-repre
relative to day 0 or GFP shRNA.
(F) ChIP-qPCR analysis of Oct4 and Nanog occupancy at Wdr5 locus. Numbere
negative control. Values are expressed as fold enrichment relative to input DNA
Data are represented as mean ± SD; n = 3. See also Figure S1.mined our previous microarray data (Ivanova et al., 2006) and
published iPS cell data sets for expressions of trxG complex
members. Wdr5 emerged as an obvious candidate, as its
expression was downregulated upon differentiation (Figure 1A)
and upregulated during iPS cell formation (Figure S1A), unlike
other members whose expression levels were incoherent among
the data sets. Interestingly, the upregulation of Wdr5 in iPS cells
was independent of the somatic cell types chosen for reprog-
ramming. We also observed higher Wdr5 and H3K4me3 levels
in ES cells than in somatic cells and tissues (Figures S1B and
S1C), suggesting specific Wdr5 functions in ES and iPS cell
maintenance.
We next validated our microarray data and observed amarked
Wdr5 reduction, similar to Oct4 and Nanog, with concomitant
decreases in global H3K4me3 (Figure 1B). Wdr5 diminution in
embryoid body (EB) assays indicated that this was not specific
to retinoid acid (RA) induction but was generally representative
of differentiation (Figure 1C). Additionally, when we depleted
Oct4 or Nanog using short hairpin RNA (shRNA), we also
observed a reduction in Wdr5 (Figure 1D). This effect was not
unique to the shRNAs, as Wdr5 decreases were also observed
using the Nanog-inducible and Oct4-repressible ES cell lines
(Figure 1E). Furthermore, chromatin immunoprecipitation
(ChIP) confirmed Oct4 and Nanog occupancy in intron 1 of
Wdr5 (Figure 1F). These data indicate that Wdr5 expression
correlates positively with the undifferentiated state and that the
Wdr5 gene is a downstream target of Oct4 and Nanog.
Wdr5 Is a Regulator of ES Cell Self-Renewal
We next designed shRNAs targeting Wdr5 to determine whether
it is required for self-renewal. Wdr5 shRNA-2 and -4 effectively
depletedWdr5mRNA and protein levels, but not those encoding
other WD repeat proteins (Figure 2A and Figure S1D). Wdr5
knockdown induced changes in cell morphology and decreased
alkaline phosphatase (AP) activity, indicative of differentiation
(Figure 2B). In ES cell competition assays, Wdr5 depletion
resulted in loss of self-renewal similar to depletion of LIF receptor
(LIFR) or Nanog (Figure 2C). Furthermore, depletion of Wdr5
diminished secondary ES colony formation (Figure 2D) and
reduced self-renewal gene expression while increasing ecto-
dermal and trophectodermal gene expressions (Figure S1E).
Importantly, Wdr5 depletion induced the collapse of the
extended ES cell transcriptional network (Figure 2E).
To rule out shRNA off-target effects, we built complementation
‘‘rescue’’ ES cell lines (Wdr5R) where endogenous Wdr5 was
constitutively repressedbyWdr5-shRNAand rescuedby aDoxy-
cycline-inducible (Dox) shRNA-immune Wdr5 (Figure 2F).
Removal of Dox resulted in loss of self-renewal gene expression
in two independent clones, whereas, in the presence of Dox,
expression remained at normal levels (Figure 2F, right). This
was also evident from AP staining (Figure S2A). Global gene
expression profiling and gene set enrichment analyses (GSEA)ssible lines (Schaniel et al., 2009). All data are normalized to actin and shown
d gray bars indicate primer locations. Glutathione S transferase (GST) ChIP as
and a control region (Loh et al., 2007).
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Figure 2. Wdr5 Depletion Results in Loss of Self-Renewal and Collapse of Extended Transcriptional Network
(A) Real-time PCR (left) and immunoblot (right) analyses after 4 days Wdr5 knockdown.
(B) AP staining after 4 days shRNA knockdown.
(C) ES cell competition assay (Ivanova et al., 2006) in E14 and CCE cells. Luciferase (LUC), Nanog, and LIFR shRNAs serve as negative and positive controls,
respectively.
(D) Secondary ES colony replating assay (Tay et al., 2008). Circles depict colonies from the 600 cell-replated wells.
(E) Gene expression of composite transcriptional network (Chen et al., 2008; Kim et al., 2008) after 4 days Wdr5 depletion as measured by real-time PCR.
Log2 fold change relative to GFP shRNA.
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demonstrated that Wdr5 depletion repressed self-renewal and
enhanced primarily ectoderm differentiation (Figure 2G and
Figure S2B). Gene ontology (GO) analysis of the differentially
expressed genes revealed enrichment in categories like devel-
opmental processes, mesoderm and skeletal development,
and others (Figure S2C). Arguing against induced apoptosis or
a general loss of proliferative potential, Wdr5 depletion in ES
cells resulted in no change in apoptotic gene expressions,
whereas cell-cycle analysis showed only a marginal impediment
(Figures S2D and S2E). Indeed, sporadic clusters of viable cells
expressing lineage-specific markers, nestin and smooth muscle
actin, were detectable after extended periods of Wdr5 knock-
down (Figure S2F). In addition, Wdr5 depletion in fibroblasts
and myoblasts induced no significant changes in cell cycle, sug-
gesting that Wdr5 has specific roles in maintenance of ES cell
self-renewal (Figure S2G–S2I).
We next asked whether Wdr5 overexpression was sufficient
to block differentiation in EB assays using the Wdr5R (Fig-
ure S2J). Wdr5 overexpression (+Dox) delayed trophectoderm
and mesoderm differentiation (Figures S2K and S2L) and
enhanced endoderm differentiation (Figure S2N) but failed to
prevent loss of self-renewal genes (Figure S2O). Conversely,
Wdr5 repression enhanced commitment to trophectoderm and
endoderm yet accelerated the loss of self-renewal markers
(Figures S2K, S2N, and S2O). The enhanced differentiation
following knockdown of Wdr5 also argues against a general
loss of cell viability. Finally, transient overexpression of Wdr5
under self-renewing conditions resulted in no change in ES cell
identity (data not shown). Collectively, these results show that
Wdr5 plays specific roles in maintaining an intact ES cell
transcriptional network and, consequently, a self-renewal
phenotype but is insufficient to block differentiation.
Wdr5 Maintains Global and Localized
H3K4 Trimethylation
We further pursued the mechanism by which Wdr5 regulates
self-renewal. Wdr5 is known to be required for H3K4me3
modification and HOX gene activation (Wysocka et al., 2005).
As expected, Wdr5 knockdown reduced the amount of Wdr5
in chromatin and global H3K4me3 levels (Figure 3A). Moreover,
we observed that the reduction in H3K4me3 precedes downre-
gulation of Oct4, Nanog, or SSEA1 markers (Figure 2F, left). At
2 days after Wdr5 depletion, whereas no change in Oct4 or
Nanog levels was detectable, H3K4me3 levels were evidently
reduced by more than 50%. This diminution continued and
becamemoremarked at day 4.We reason that H3K4me3 reduc-
tion is even more significant at day 4, after the initiation of Oct4
downregulation, because Wdr5 is a downstream target gene of
Oct4. Thus, depletion of Oct4 could further attenuate the tran-
scription of Wdr5 and, consequently, expression levels of global
H3K4me3. Additionally, a significant SSEA1 decrease was only(F) Scheme of tetracycline-inducible Wdr5 rescue construct (top). Immunoblot a
reduction preceding the loss of Oct4 and Nanog. Real-time PCR analysis (right) af
#4 and #12). All data are normalized to actin and shown relative to Vector, GFP s
(G) GSEA of a gene set representing self-renewal markers upon Wdr5 knockd
discovery rate.
See also Figure S1 and Figure S2.detected after day 3 (Figure S3A).These data indicate that loss
of H3K4me3 is a direct result of Wdr5 depletion and not an indi-
rect result of the loss of pluripotency factors such as Oct4 or
Nanog.
We further detected decreases in H3K4me3 at the Pou5f1 and
Nanog loci upon Wdr5 depletion (Figure 3B). H3K4me3 reduc-
tion also occurred at pluripotency-associated gene promoters
where we had shown decreased expression levels (Figure 3C),
as well as at ‘‘bivalent’’ promoters and at other promoters
(Figure S3B). In line with the role of H3K4me3 in RNA polymerase
II (RNAP-II) recruitment (Wang et al., 2009), Wdr5 loss reduced
RNAP-II occupancy atNanog, Sox2, Fbx15, andMyc genes (Fig-
ure 3D). Moreover, using a Nanog-reporter line (Schaniel et al.,
2009), Wdr5 depletion reduced Nanog promoter activity (Fig-
ure S3C). Knockdowns of two other trxG-associated members
Ash2l and Menin (Shilatifard, 2006) also induced ES cell differen-
tiation (Figure S3D). This strongly suggested that the mainte-
nance of self-renewal requires elevated H3K4me3 expression.
Collectively, these data indicate thatWdr5 is critical for themain-
tenance of global and localized H3K4me3 and for transcriptional
activation in ES cells.
Wdr5 Interacts with Oct4 in ES Cells
The indispensible role of Wdr5 in self-renewal suggested
probable physical interactions with components of the core
transcriptional network. Coimmunoprecipitation (co-IP) using
an Oct4 antibody demonstrated an interaction with Wdr5 (Fig-
ure 4A). To confirm the Wdr5-Oct4 interaction, we derived ES
cell lines in which Wdr5 was tagged with Flag or Myc epitopes
and selected for clones that had minimumWdr5 overexpression
(Figure S4A). Additionally, we measured self-renewal and differ-
entiation markers to pick clones that were statistically indistin-
guishable from the control line (Figures S4B andS4C). A resultant
Wdr5_FL2 line had typical growth rates andmorphology andwas
capable of in vitro and in vivo differentiation (Figures S4D–S4F),
demonstrating bona fide pluripotency. Using this line, we
successfully co-IPed Wdr5 with Oct4 (Figure 4A), as well as
Nanog and Sox2 (data not shown). Co-IP of other trxG-associ-
ated members, Rbbp5 and Menin, suggested that these factors
exist in functionally active protein complexes. We next per-
formed a gel filtration experiment to ask whether Oct4 is part of
the larger trxG complex (Figure 4B). We observed that, whereas
Oct4 is enriched primarily at molecular weight (MW) fractions
between 150 and 50 kDa and Wdr5, Ash2l, and Rbbp5 are en-
riched primarily at > 600 kDa MW fractions, there were several
fractions in which substantial amounts of Oct4 coeluted with
the core trxG-associated proteins (Figure 4B, orange box).
Interestingly, we also observed Wdr5 to be the major protein
coeluting at peak Oct4 fractions in the absence of Ash2l or
Rbbp5 (Figure 4B, blue). This suggests that the Wdr5-Oct4
partnership might extend beyond HMT activity alone.nalysis after Dox withdrawal in Wdr5R #4 (left). Orange box shows H3K4me3
ter 5 daysWdr5 knockdown (dox) or with rescue (+dox) in two clones (Wdr5R
hRNA, or Luc rescue clone (LucR). Data are represented as mean ± SD; n = 3.
own. NES, normalized enrichment score; p = nominal p value; FDR = false
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Figure 3. Wdr5 Maintains Global and Localized H3K4 Trimethylation
(A) Immunoblot after 4 days Wdr5 knockdown. WCE, whole-cell extract.
(B and C) ChIP-qPCR analysis of H3K4me3 mark at various loci after Wdr5 knockdown. Numbered gray bars indicate primer locations.
(D) ChIP-qPCR analysis of RNAP-II localization at various loci after Wdr5 knockdown. Values are expressed as fold enrichment relative to input DNA and a control
region.
All data are represented as mean ± SD; n = 3; *p < 0.005. See also Figure S3.We continued to validate the Wdr5-Oct4 interaction using
epitope-tagged proteins expressed in 293T cells (Figure 4C).
Oct4-IP successfully pulled down Wdr5, whereas the reciprocal
IP was less efficient, presumably because Wdr5 gets competed188 Cell 145, 183–197, April 15, 2011 ª2011 Elsevier Inc.away by endogenous interacting partners.We also performed an
in vitro binding assay using recombinant Wdr5 and Oct4 (Fig-
ure 4D). Encouragingly, we observed co-IP of recombinant
Wdr5 using an antibody specific for Oct4. However, this
pull-down was significantly weaker than in co-IPs in ES or 293T
cells, suggesting that whereasWdr5 and Oct4 are direct interac-
tion partners, the interactionmight be further stabilized in amulti-
meric complex.
It was shown previously that strong Myc-DNA binding is posi-
tively correlated with ‘‘euchromatic clusters’’ that bear high
H3K4me3 levels (Guccione et al., 2006). Therefore, we hypothe-
sized that Oct4 binding to DNA may also be dependent on
certain epigenetic features and be mediated through Wdr5. To
investigate this, we performed a sequential peptide-IP experi-
ment (Figure 4E, box). As expected, biotinylated-peptide pull-
down assays demonstrated strong Wdr5 specificity toward the
H3K4me3 peptide in stringent salt conditions (Figure S4G).
Flag-IP of the Wdr5-Oct4 complex (IP1) followed by peptide-IP
(IP2) demonstrated specificity of Oct4 for the H3K4me3 peptide.
Increased salt concentration retained the affinity of Wdr5 for
H3K4me3 but abolished the interaction with Oct4 (Figure 4E).
These data point to indirect interactions of Oct4 with
H3K4me3-modified histones, mediated by Wdr5, and suggest
that portions of the ES cell genome that are ‘‘visible’’ to Oct4
could be restricted by higher-order chromatin organization.
Wdr5 and Oct4 Share Overlapping Gene Regulatory
Functions
What is the functional importance of the Wdr5-Oct4 interaction?
We postulated that Oct4 would be required to recruit Wdr5 to
self-renewal-associated gene promoters, and this in turn main-
tains robust H3K4me3. Indeed, Oct4 depletion decreased
Wdr5 binding as well as H3K4me3 modification at promoters
(Pou5f1, Nanog, and Sox2) cobound by Wdr5 and Oct4 (Fig-
ure 4F). In contrast, at genes (Adfp and Gnl3) bound by Wdr5,
but not by Oct4, we detected increased Wdr5 binding and
H3K4me3 modification upon Oct4 depletion. This suggests
that the Wdr5-Oct4 partnership performs specific roles at
promoters of self-renewal genes and Wdr5 also performs
discreet transcriptional functions without the participation of
Oct4.
To assess the global extent of gene regulation, we compared
differentially expressed genes upon depletion of Wdr5 or Oct4
(Table S2). 1532 and 646 genes were differentially expressed
after Wdr5 or Oct4 knockdown, respectively, with 329 common
genes (Figure 4G). Interestingly, GSEA showed high enrichment
of Oct4-activated genes in control ES cells that become
repressed upon Wdr5 depletion (Figure 4H and Figure S5A).
Conversely, Oct4-repressed genes became enriched only
upon loss of Wdr5. GSEA comparisons with published ChIP
data sets of bivalent promoters and transcription factor binding
targets provided additional evidence that Oct4 and Wdr5 share
significant overlapping gene regulatory functions (Figure S5B
and S5C).
Genome-wide Mapping of Wdr5, Rbbp5, H3K4me3,
and Oct4 Localizations Using ChIP Sequencing
To determine the direct transcriptional targets of Oct4 andWdr5,
wemapped the DNA-binding sites forWdr5 andOct4, along with
Rbbp5 and H3K4me3, by ChIP sequencing (Figure S6A).
Comparison with published H3K4me3- and Oct4-ChIP-seq
data sets exhibited strong overlap in target genes and localbinding profiles (data not shown), as well as high colocalization
frequencies of binding regions (Figure 5D). Importantly, ChIP-
qPCR validation revealed a low false discovery rate (FDR) for
the identified binding regions (Figure S6B).
In support of our earlier observations (Figures 4G and 4H), the
distributions of Oct4 andWdr5 localization were strikingly similar
(Figures 5A and 5B), wherein 75% of Oct4 target genes were co-
bound byWdr5 (Figure 5C). In line with a recent report (Kim et al.,
2010), clustering of the colocalization frequencies of histone
modifications, transcription factors, and transcriptional regula-
tory proteins recapitulated Polycomb (Figure 5D, blue), ES core
(red), and Myc modules (green). Evidently, Oct4 and the core
module share no significant overlap with regions of the genome
marked by H3K27me3, H3K36me3, or H3K9me3 modifications.
As expected, Wdr5 and Oct4 share a strong correlation in their
binding regions and serve to bridge the Myc and the core
modules (red-green). Lastly, the top Oct4-bound genes have
significantly higher Wdr5 ChIP-seq signals than the bottom
Oct4-bound genes (Figure 5E). The converse was also true,
providing additional evidence that Oct4 and Wdr5 are partners
in transcriptional regulation.
Wdr5, Rbbp5, and H3K4me3 binding regions are largely
located within Refseq promoters (Figure 5A) and overrepre-
sented in gene-rich chromosomal regions (Figure S6C) and
share a strong overlap in their binding targets (Figure 6A). We
identified 9303 Wdr5, Rbbp5, and H3K4me3 coassociated
target genes, termed trxG hereafter. In line with the gene activa-
tion role of trxG (Ringrose and Paro, 2004), the level of mRNA
expression in ES cells was directly proportional to the intensity
of trxG ChIP-seq signals (Figure 6B). Lastly, a large proportion
of trxG target genes contained ‘‘bivalent’’ domains (Table S3
and Figure S6D) and GO enrichment in categories like develop-
mental processes, neurogenesis, embryogenesis, mesoderm,
and ectoderm development (Figure S6E).
Oct4, Sox2, Nanog, and trxG Cooperate
in Transcriptional Activation
We sought to understand the extent to which the known tran-
scriptional network cooperates with trxG in gene regulation by
broadening our analyses to include genes bound by trxG as
well as Oct4 (this study), Sox2, and Nanog (Marson et al.,
2008) (OSN) (Table S1). Oct4, Sox2, and Nanog are known to
possess both transcriptional activation and repression functions,
but the specific mechanisms that distinguish between these two
properties remain elusive (Marson et al., 2008). We hypothesized
that, because trxG is required for transcriptional activation (Ring-
rose and Paro, 2004), it would work with OSN specifically for this
function. We identified four markers of active transcription from
published reports (Marson et al., 2008; Mikkelsen et al., 2007;
Rahl et al., 2010)—H3K79me2, H3K36me3, elongating RNAPII (-
RNAPII-Ser2P), and Paf1 complex (Ctr9) binding—and a marker
of repression, H3K27me3 (Mikkelsen et al., 2007). As described
previously (Rahl et al., 2010), cMyc targets are highly positive for
all four activation marks, whereas Suz12 targets are largely
H3K27me3 positive (Figure 6C, top). Next, we observed trxG
and Oct4 targets to be significantly activated above baseline
levels. Additionally, target genes with OSN co-occupancy were
preferentially more active than targets occupied by Oct4 alone,Cell 145, 183–197, April 15, 2011 ª2011 Elsevier Inc. 189
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See also Figure S6 and Table S4.in line with the hypothesis that these transcription factors act
synergistically for gene activation (Kim et al., 2008).
Five sectors, [I]–[V], of genes were identified based on their
occupancies by trxG and/or OSN (Figure 6D) (Table S3). We
then asked what is the percentage of genes in sectors [I]-[V] con-
taining thesemarks of activation. Remarkably, the percentage of
active genes was highest in sector [I] and was as high as that for
cMyc, a strong transcriptional activator (Figure 6C, bottom). In
contrast, the percentage of active genes was markedly reduced(F) ChIP-qPCR analysis of Oct4 binding and Wdr5 binding and H3K4me3 levels a
ZHBTc4. Control denotes intergenic region bound neither by Wdr5 nor Oct4. H
represented as mean ± SD; n = 3.
(G) Venn diagram of differentially expressed genes inWdr5- andOct4-depleted ES
(H) GSEA analyses of two gene sets representing Oct4-activated (left) and Oct4
expression; blue, low expression). Note the similarity to Figure S5A.
See also Figure S4, and Figure S5, and Table S2.in the absence of OSN or trxG co-occupancies, represented by
sectors [II] and [III], respectively. This trend was not observed
using the H3K27me3 repressive mark.
What are the properties of the genes in sectors [I], [II], and [III],
and how do their expressions change upon differentiation?
Using GSEA, we observed that: (1) OSN and trxG cobound
genes (sector [I]) represented key self-renewal regulators (e.g.,
Oct4, Nanog, and Sox2) that are highly expressed in undifferen-
tiated ES cells as indicated by a highly positive normalizedfter 2 days Oct4 depletion. Values are expressed as fold enrichment relative to
eatmap shows Log2 expression of genes upon Oct4 depletion. All data are
cells. p value for overlap as computed usingMonte Carlo simulation is < 1e08.
-repressed (right) genes. Heatmap represents top enriched genes. (Red, high
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enrichment score (NES) of +1.93 (Figure 6E, column 1); (2) OSN
without trxG cobound genes (sector [II]) represented ‘‘auxiliary’’
pluripotency-associated regulators (e.g., Dppa3, Fbxo15, and
Gdf3). This gene set is not as highly expressed in ES cells, as
indicated by a lowered NES of +1.59, andmight share redundant
functions with sector [I] genes (Figure 6E, column 2); (3) trxG
without OSN cobound genes (sector [III]) represented primarily
developmental regulators (e.g., Dhx16, Hoxa9, and Tnni1) that
are highly expressed only in differentiated cells, as indicated
by a highly negative NES of 1.5 (Figure 6E, column 3). These
findings suggest that the OSN transcriptional circuitry and trxG
are accomplices in transcriptional activation of key self-renewal
genes.
Wdr5 Is Required for Efficient Somatic
Cell Reprogramming
It remains unclear how OSKM with no immediate histone modi-
fication activities reconfigure the epigenome during somatic cell
reprogramming. Notably, we observed upregulation of Wdr5
during iPS cell generation (Figures 7A and 7B), which led us to
hypothesize that Oct4 partners with Wdr5 to reset the epige-
nome during iPS cell formation. Therefore, we asked whether
Wdr5 is indeed required for reprogramming of mouse embryonic
fibroblast (MEF) from Oct4 GFP reporter mice (Figure S7A).
Specific downregulation of Wdr5 in MEFs (Figure S7B) reduced
the number of iPS colonies, as scored by colony morphology
(Figure S7C), Oct4 GFP expression (Figure 7C), and number of
AP-positive colonies (Figure 7D). This observation was not due
to an adverse effect of Wdr5 depletion on the proliferative
capacity of MEFs (Figure 7E and Figure S7D). Our cell-cycle
analyses in 3T3 fibroblasts further support this observation
(Figure 2I). Oct4-GFP-positive colonies emerging in the Wdr5
knockdown cultures either had not been infected by the shRNA
lentivirus or had silenced it, as determined byWdr5 RT-PCR (Fig-
ure S7E). We next asked whether Wdr5 is required for the early/
initiation phase or the later/expansion phase of reprogramming
by depleting Wdr5 before (day 5), simultaneously with (day 0),
and after (day +4, +8) OSKM introduction. The most marked
attenuation in iPS colony formation was observed when Wdr5
was depleted during the initial stages of reprogramming (Fig-
ure 7F). Moreover, this reduction in iPS efficiency was measur-
able very early (day 8) in reprogramming using AP and SSEA1
as ‘‘surrogate’’ markers of pluripotency before endogenous
Oct4 is activated (Figure 7G). This reduction was observed as
late as day 20, arguing against a mere delay in reprogramming.
Taken together, these data suggest that OSKM requires robust
Wdr5 activity for effective somatic cell reprogramming.Figure 6. Oct4, Sox2, Nanog, and trxG Are Partners in Transcriptional
(A) Venn diagram showing overlap of Wdr5, Rbbp5, and H3K4me3 ChIP target g
(B) 18096 Refseq genes were divided equally into three expression groups and w
25th, and 75th percentile number of ChIP-seq tags. Whiskers show 2.5th and 97
(C) Proportion (%) of each gene set (colored bars), extracted from published (Che
markers of active and repressive transcription. Wdr5, Rbbp5, and H3K4me3 cobo
(D) Chart showing number of trxG- and OSN-bound genes subclassified into five
OSN_all; and [V], trxG_all.
(E) Table containing GSEA (top row) of mRNA expressions upon EB differentiati
ChIP-seq binding profiles (bottom row) for genes in sectors [I]–[V]. See also FiguDISCUSSION
The significance of our study is three fold. First, our work repre-
sents the detailed characterization of a core trxG member in the
maintenance of ES cell self-renewal. PcG-associated members
have been well characterized in this context. Knockout ES cells
for PcG have been established, genome-wide binding targets
have been investigated in both mouse and human ES cells
(Surface et al., 2010), and recently, multiple groups have per-
formed PcG pull-down experiments to identify Jumonji domain
proteins as critical mediators of pluripotency (Landeira and
Fisher, 2010). In contrast, there exist few complementary studies
for trxG-associated members. Although not a cell-/tissue-
specific factor like Oct4, we observed that elevated Wdr5
expression appears to be a unique and defining property of
pluripotent ES and iPS cells. Despite the identification of bivalent
domains, it is unclear whether the H3K4me3 modification is
required for transcriptional activation of self-renewal genes.
Here, we reduced H3K4me3 levels through the perturbation of
a core trxG protein and observed significant attenuation in self-
renewal gene expressions that eventually leads to the induction
of differentiation. Reduction, but not complete ablation, of
H3K4me3 in our shRNA experiments allowed us to observe
this self-renewal defect. We predict that a complete removal of
Wdr5 and, consequently, the H3K4me3 mark would result in
a possibly lethal phenotype that bypasses self-renewal mainte-
nance. We have provided significant data to suggest that the
consequence of losing Wdr5 is, in part, mediated through the
loss of H3K4me3. However, it remains possible that Wdr5 inter-
acts with other factors, apart from Oct4, and performs functions
that are distinct from H3K4me3 modification that also could
result in loss of pluripotency.
Additionally, our data supplements published work on Chd1
and Tip60-p400 complex. Chd1 was shown to be essential for
open chromatin, pluripotency, and reprogramming (Gaspar-
Maia et al., 2009). These results support our findings, as Chd1
is a ‘‘reader’’ of the H3K4me3 mark and our complementary
results show Wdr5 to be a ‘‘presenter’’ of H3K4. We indeed
observed increased expression of H3K4me3 and acetylated
H3K9/14 in ES cells compared to somatic cells, which presum-
ably maintains the ES cell epigenome in its open and transcrip-
tionally permissive state. Fazzio et al. reported that reduced
H3K4me3 diminished Tip60-p400 recruitment to chromatin
and induced loss of ES cell identity (Fazzio et al., 2008). These
studies, including our work, collectively indicate that the
H3K4me3 mark is an indispensible histone mark that regulates
the balance between self-renewal and lineage commitment.Activation
enes.
ere plotted against each ChIP-seq tag signal. Box plots show median (red bar),
.5th percentile.
n et al., 2008; Marson et al., 2008) and current ChIP-seq data sets, containing
und (trxG). All Refseq (gray bar, black-dotted line) genes represent baseline %.
sectors. [I], OSN and trxG; [II], OSN without trxG; [III], trxG without OSN; [IV],
on (Perez-Iratxeta et al., 2005), representative gene names (middle-row), and
re S6 and Table S1 and Table S3.
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Figure 7. Increased Wdr5 Expression Is Required for Reprogramming of Oct4-GFP MEFs by Defined Factors
(A) Immunoblot of two independent iPS clones and their parental MEFs.
(B) Real-time PCR of trxG-associated members during iPS induction. Data are normalized to actin and are shown relative to MEF. Data are represented as
mean ± SD; n = 3.
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Second, we put forward an integrated transcriptional network-
epigenetic regulatory model for themaintenance of self-renewal.
We and others have shown that H3K4me3 marks a large propor-
tion of the ES cell genome, including promoters that are unre-
lated to self-renewal. How then can the self-renewal function
of Wdr5/H3K4me3 be conferred? We propose that the locus
specificity of Wdr5 is, in part, conferred through its direct and
functional interaction with Oct4. We focused on the Oct4-Wdr5
interaction because Oct4 is a master regulator of pluripotency
and is the only factor that until recently remained irreplaceable
in reprogramming (Heng et al., 2010). However, at least in
some experiments, we did observe co-IP of Sox2 and Nanog,
suggesting that Wdr5 may interact with a more extensive
complex of transcription factors. A recent study reported an
Oct4-interactome of 166 proteins, which included transcription
factors and chromatin-modifying complexes, many of which
were not previously known to associate with the ES cell network
(Dejosez et al., 2010; van den Berg et al., 2010). The Wdr5-Oct4
interaction was also observed there. Our mechanistic work on
Wdr5 therefore elucidates the functional importance of this inter-
action and possibly sheds light on the relevance of Oct4’s
surprisingly broad range of interaction partners. We also deter-
mined that trxG and the OSN-triad colocalize at key self-renewal
regulatory genes and synergistically maintain their robust
expression levels. Gene promoters that are only OSN bound
or only trxG bound are less likely to be transcriptionally active
in ES cells. Our genome-wide localization analyses of Wdr5
and Rbbp5 represent the first unbiased, high-resolution
mapping of core trxG member occupancy in any cell/tissue
type and thus provide a valuable resource for future investigation
of trxG-mediated gene regulation and potential TRE-motif
discovery (Table S4).
Lastly, we established that Wdr5 is required for the initial
reconfiguration phase of somatic cell reprogramming. We
propose that the Wdr5-Oct4 partnership accomplishes this as
follows (Figure 7H). First, Oct4 enhances basal Wdr5 expression
in MEFs (blue arrow) through direct binding and transcriptional
activation of its promoter. Next, the DNA specificity conferred
by Oct4 directs Wdr5 to genomic loci encoding self-renewal
genes, such as Pou5f1 and Nanog, to re-establish a H3K4me3
high chromatin signature (green arrow). This elevated expression
of H3K4me3 subsequently facilitates strong Oct4 occupancy to
direct robust transcriptional activation (red arrow), presumably in
conjunction with the larger trxG complex. Finally, the positive
feedback loop set up by Oct4 targeting Wdr5 (purple arrows)
allows for the establishment of iPS cells or the maintenance of
ES cell self-renewal. EB and RA differentiation or trxG member
depletion compromises the maintenance of self-renewal and
triggers differentiation.(C) High and low GFP-positive colonies were counted 14 days post-OSKM in W
(D) AP staining of entire wells (circles) and representative colonies (squares) from
(E) MTT proliferation assay of MEF transduced with Luc or Wdr5 shRNA.
(F) Wdr5 depletion during iPS reprogramming. GFP+++ colonies counted at day 1
(G) AP, SSEA1, and GFP intensity assessed at early (day 8) or late stages (day 20)
of entire wells (circles) and representative SSEA1 colonies (squares) is depicted.
(H) Proposed model.
See also Figure S7.In summary, the work presented here elucidates a previously
unrecognized interconnectivity between the core transcriptional
network and selectmembers of the trxG complex, reveals impor-
tant insights into the role of Wdr5/H3K4me3 in the maintenance
of ES cell self-renewal, and suggests how Oct4 downstream
target epigenetic factors reconfigure the H3K4me3 signature
during the process of somatic cell reprogramming.
EXPERIMENTAL PROCEDURES
Cell Culture and Differentiation Assays
Mouse ES cell lines—E14T, CCE, J1, ZHBTc4, NanogR, and Wdr5R—were
cultured and differentiated as previously described (Ivanova et al., 2006).
Dermal papilla, dermal fibroblasts, and MEFs were derived as described
previously (Tsai et al., 2010).
Gene Expression Microarray, GO, and GSEA
Microarrays were conducted on Illumina Beadchip arrays. All data were
normalized using LumiR. Differentially expressed genes were identified using
Limma: Log2FC > 0.6 or < 0.6; adjusted p value < 0.05; and detection prob-
ability > 0.99. Microarray data deposited at GEO (GSE19588). Cluster 3.0 and
Java Treeview were used for data visualization. GO was performed at http://
www.pantherdb.org/. GSEA was performed at http://www.broadinstitute.
org/gsea/.
Real-Time Quantitative PCR and Immunoblotting
Total RNAwas Trizol extracted, column purified, and reverse transcribed using
the High Capacity kit (Applied Biosystems). For ChIP-qPCR analysis, 1 ng
ChIP-DNA was used for each PCR. All qPCR analyses were performed using
Fast SYBR Green (Applied Biosystems). To obtain whole-cell protein extracts,
cells were lysed in RIPA buffer. Primer sequences and antibodies are available
in Supplemental Information and Table S6.
Short Hairpin RNA Design
Target sequences: Wdr5 shRNA2, GCCGTTCATTTCAACCGTGAT; Wdr5
shRNA4, GCAAGTTCATCTGCTGATA; Oct4 shRNA, GAAGGATGTGGTTCGA
GTA; Nanog shRNA, GAACTATTCTTGCTTACAA; Menin shRNA, GTAGATTT
CCGCACTTTAT; and Ash2l shRNA, CGAGTCTTGTTAGCCCTACAT.
Co-IP and ChIP Assay
ES cells were lysed in Buffer G, incubated overnight with 5 ug antibody, and
captured with Protein G beads. Protein complexes were eluted by boiling in
loading buffer. 10 ul was used for each immunoblot with 2% input. Epitope-
tagged co-IP in 293T cells was performed with Flag and Myc antibodies in
Buffer G. ChIP was performed as described previously (Schaniel et al., 2009).
Biotinylated Peptide IP
Biotinylated peptides were synthesized and conjugated to streptavidin beads.
ES cell extracts were prepared in Buffer G and incubated with peptide-conju-
gated beads. Beads were washed and eluted in loading buffer.
Gel Filtration and In Vitro Binding Assay
Gel filtration was performed in DuoFlow BioLogic System according to manu-
facturer’s manual (Biorad). In vitro binding assay was conducted in Buffer
G with purified Pou5f1 and Wdr5 (Origene).dr5 and Luc knockdown cells. Data are represented as mean ± SD.
Wdr5 and Luc knockdown iPS colonies at day 14.
4. OSKM only did not receive Wdr5 shRNA.
of iPS induction with (green bar) or without (black bar) Wdr5 shRNA. AP staining
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Generation of iPS Cells
As described previously (Tsai et al., 2010), Oct4-GFP MEFs were transduced
with pMX-Oct4, Sox2, Klf4, and cMyc retroviruses and were cultured in ES
media on irradiated MEFs. GFP-positive colonies were counted after
14 days posttransduction.
ChIP Sequencing and Data Analysis
ChIPed DNA was blunt ended, linker ligated, amplified, and applied to the
flow-cell using the Solexa Cluster Station (Illumina). Samples were subjected
to 36 cycles of sequencing using the Genome Analyzer II (Illumina) (see Table
S5). Images acquired were processed through the image extraction pipeline
and aligned to mouse NCBI build mm9 using ELAND. ChIP-seq data was
deposited at GEO (GSE22934).
ACCESSION NUMBERS
All microarray data are deposited at GEO database with project number
GSE19588. All ChIP-seq data are deposited at GEO database with project
number GSE22934.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and six tables and can be found with this article online at doi:10.1016/j.
cell.2011.03.003.
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